RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Changes in Buprenorphine prescribing to Medicaid beneficiaries during the first year of the COVID-19 pandemic
Dowd, W. N., & Mark, T. L. (2022). Changes in Buprenorphine prescribing to Medicaid beneficiaries during the first year of the COVID-19 pandemic. JAMA network open, 5(3), e224058. Article 224058. https://doi.org/10.1001/jamanetworkopen.2022.4058
This cross-sectional study compares trends in prescribing buprenorphine to all Medicaid beneficiaries before and after the start of the COVID-19 pandemic.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.
